MeCP2 co-ordinates liver lipid metabolism with the NCoR1/HDAC3 corepressor complex

Human Molecular Genetics

Volumn 25, Issue 14, 2016, Pages 3029-3041

  Kyle, Stephanie M ^a,b   Saha, Pradip K ^b   Brown, Hannah M ^b,d   Chan, Lawrence C ^b   Justice, Monica J ^a,b,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 3; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LIPID; METHYL CPG BINDING PROTEIN 2; RECEPTOR INTERACTING PROTEIN 140; HISTONE DEACETYLASE; MECP2 PROTEIN, HUMAN; MECP2 PROTEIN, MOUSE; NCOR1 PROTEIN, MOUSE;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DYSLIPIDEMIA; ENERGY CONSUMPTION; FATTY LIVER; FEMALE; GENE DELETION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIPID HOMEOSTASIS; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; LIVER CELL; LIVER METABOLISM; LONGEVITY; MACROPHAGE; MALE; METABOLISM; MOUSE; NEUROLOGIC DISEASE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RETT SYNDROME; ANIMAL; BRAIN; DISEASE MODEL; GENETICS; LIVER; MUTATION; PATHOLOGY;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; HISTONE DEACETYLASES; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MALE; METHYL-CPG-BINDING PROTEIN 2; MICE; MUTATION; NUCLEAR RECEPTOR CO-REPRESSOR 1; RETT SYNDROME; SEQUENCE DELETION;

EID: 85015290430     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddw156     Document Type: Article

References (61)

1. Amir, R.E., Van den Veyver, I.B., Wan, M., Tran, C.Q., Francke, U. and Zoghbi, H.Y. (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet., 23, 185-188.
2. Braunschweig, D., Simcox, T., Samaco, R.C. and LaSalle, J.M. (2004) X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain. Hum. Mol. Genet., 13, 1275-1286.
3. Guy, J., Hendrich, B., Holmes, M., Martin, J.E. and Bird, A. (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet., 27, 322-326.
4. Katz, D.M., Berger-Sweeney, J.E., Eubanks, J.H., Justice, M.J., Neul, J.L., Pozzo-Miller, L., Blue, M.E., Christian, D., Crawley, J.N., Giustetto, M. et al. (2012) Preclinical research in Rett syndrome: setting the foundation for translational success. Dis. Model. Mech., 5, 733-745.
5. Young, J.I. and Zoghbi, H.Y. (2004) X-Chromosome Inactivation Patterns Are Unbalanced and Affect the Phenotypic Outcome in a Mouse Model of Rett Syndrome. Am. J. Hum. Genet., 74, 511-520.
6. Adams, V.H., McBryant, S.J., Wade, P.A., Woodcock, C.L. and Hansen, J.C. (2007) Intrinsic Disorder and Autonomous Domain Function in the Multifunctional Nuclear Protein, MeCP2. J. Biol. Chem., 282, 15057-15064.
7. Skene, P.J., Illingworth, R.S., Webb, S., Kerr, A.R.W., James, K.D., Turner, D.J., Andrews, R. and Bird, A.P. (2010) Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol. Cell, 37, 457-468.
8. Ausĭo, J., Paz, AM. de and Esteller, M. (2014) MeCP2: the long trip from a chromatin protein to neurological disorders. Trends Mol. Med., 20, 487-498.
9. Ebert, D.H., Gabel, H.W., Robinson, N.D., Kastan, N.R., Hu, L.S., Cohen, S., Navarro, A.J., Lyst, M.J., Ekiert, R., Bird, A.P. et al. (2013) Activity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction withNCoR. Nature, 499, 341-345.
10. Lyst, M.J., Ekiert, R., Ebert, D.H., Merusi, C., Nowak, J., Selfridge, J., Guy, J., Kastan, N.R., Robinson, N.D., de Lima Alves, F. et al. (2013) Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor. Nat. Neurosci., 16, 898-902.
11. Guenther, M.G., Barak, O. and Lazar, M.A. (2001) The SMRT and N-CoR Corepressors Are Activating Cofactors for Histone Deacetylase 3. Mol. Cell. Biol., 21, 6091-6101.
12. Li, J., Wang, J., Wang, J., Nawaz, Z., Liu, J.M., Qin, J. andWong, J. (2000) Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. Embo J., 19, 4342-4350.
13. Heckman, L.D., Chahrour, M.H. and Zoghbi, H.Y. (2014) Rettcausing mutations reveal two domains critical for MeCP2 function and for toxicity in MECP2 duplication syndrome mice. eLife, 3
14. Alenghat, T., Meyers, K., Mullican, S.E., Leitner, K., Adeniji-Adele, A., Avila, J., Bučan, M., Ahima, R.S., Kaestner, K.H. and Lazar, M.A. (2008) Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology. Nature, 456, 997-1000.
15. Feng, D., Liu, T., Sun, Z., Bugge, A., Mullican, S.E., Alenghat, T., Liu, X.S. and Lazar, M.A. (2011) A Circadian Rhythm Orchestrated by Histone Deacetylase 3 Controls Hepatic Lipid Metabolism. Science, 331, 1315-1319.
16. Knutson, S.K., Chyla, B.J., Amann, J.M., Bhaskara, S., Huppert, S.S. and Hiebert, S.W. (2008) Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks. Embo J, 27, 1017-1028.
17. Sun, Z., Miller, R.A., Patel, R.T., Chen, J., Dhir, R., Wang, H., Zhang, D., Graham, M.J., Unterman, T.G., Shulman, G.I. et al. (2012) Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. Nat. Med., 18, 934-942.
18. Gill, S., Stevenson, J., Kristiana, I. and Brown, A.J. (2011) Cholesterol-dependent degradation of squalene monooxygenase, a control point in cholesterol synthesis beyond HMG-CoA reductase. Cell Metab., 13, 260-273.
19. Hidaka, Y., Satoh, T. and Kamei, T. (1990) Regulation of squalene epoxidase in HepG2 cells. J. Lipid Res., 31, 2087-2094.
20. Buchovecky, C.M., Turley, S.D., Brown, H.M., Kyle, S.M., McDonald, J.G., Liu, B., Pieper, A.A., Huang, W., Katz, D.M., Russell, D.W. et al. (2013) A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome. Nat. Genet., 45, 1013-1020.
21. Justice, M.J., Buchovecky, C.M., Kyle, S.M. and Djukic, A. (2013) A role for metabolism in Rett syndrome pathogenesis: New clinical findings and potential treatment targets. Rare Dis. Austin Tex., 1, e27265.
22. Segatto, M., Trapani, L., Di Tunno, I., Sticozzi, C., Valacchi, G., Hayek, J. and Pallottini, V. (2014) Cholesterolmetabolismis altered in rett syndrome: a study on plasma and primary cultured fibroblasts derived frompatients. PLoS One, 9, e104834.
23. Guillot, F., Misslin, P. and Lemaire, M. (1993) Comparison of fluvastatin and lovastatin blood-brain barrier transfer using in vitro and in vivo methods. J. Cardiovasc. Pharmacol., 21, 339-346.
24. Saheki, A., Terasaki, T., Tamai, I. and Tsuji, A. (1994) In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors. Pharm. Res., 11, 305-311.
25. Matsumoto, M., Ogawa, W., Akimoto, K., Inoue, H., Miyake, K., Furukawa, K., Hayashi, Y., Iguchi, H., Matsuki, Y., Hiramatsu, R. et al. (2003) PKClambda in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity. J. Clin. Invest, 112, 935-944.
26. Shimomura, I., Matsuda, M., Hammer, R.E., Bashmakov, Y., Brown, M.S. and Goldstein, J.L. (2000) Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell, 6, 77-86.
27. Horton, J.D., Goldstein, J.L. and Brown, M.S. (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest., 109, 1125-1131.
28. Guilherme, A., Virbasius, J.V., Puri, V. and Czech, M.P. (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol., 9, 367-377.
29. Tschöp, M.H., Speakman, J.R., Arch, J.R.S., Auwerx, J., Brüning, J.C., Chan, L., Eckel, R.H., Farese, R.V., Galgani, J.E., Hambly, C. et al. (2012) A guide to analysis of mouse energy metabolism. Nat. Methods, 9, 57-63.
30. You, S.H., Lim, H.W., Sun, Z., Broache, M., Won, K.J. and Lazar, M.A. (2013) Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo. Nat. Struct. Mol. Biol., 20, 182-187.
31. Samaco, R.C., Fryer, J.D., Ren, J., Fyffe, S., Chao, H.T., Sun, Y., Greer, J.J., Zoghbi, H.Y. and Neul, J.L. (2008) A partial loss of function allele of Methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome. Hum. Mol. Genet, 17, 1718-1727.
32. Chahrour, M. and Zoghbi, H.Y. (2007) The story of Rett syndrome: fromclinic to neurobiology. Neuron, 56, 422-437.
33. Gong, M., Liu, J., Sakurai, R., Corre, A., Anthony, S. and Rehan, V.K. (2015) Perinatal nicotine exposure suppresses PPARc epigenetically in lung alveolar interstitial fibroblasts. Mol. Genet. Metab., 114, 604-612.
34. Hara, M., Takahashi, T., Mitsumasu, C., Igata, S., Takano, M., Minami, T., Yasukawa, H., Okayama, S., Nakamura, K., Okabe, Y. et al. (2015) Disturbance of cardiac gene expression and cardiomyocyte structure predisposes Mecp2-null mice to arrhythmias. Sci. Rep, 5.
35. Hu, B., Gharaee-Kermani, M., Wu, Z. and Phan, S.H. (2011) Essential role of MeCP2 in the regulation of myofibroblast differentiation during pulmonary fibrosis. Am. J. Pathol., 178, 1500-1508.
36. Li, C., Jiang, S., Liu, S.Q., Lykken, E., Zhao, L., Sevilla, J., Zhu, B. and Li, Q.J. (2014) MeCP2 enforces Foxp3 expression to promote regulatory T cells' resilience to inflammation. Proc. Natl. Acad. Sci. USA, 111, E2807-E2816.
37. Murphy, C., Ledmyr, H., Ehrenborg, E. and Garing;fvels, M. (2006) Promoter analysis of the murine squalene epoxidase gene. Identification of a 205 bp homing region regulated by both SREBP'S and NF-Y. Biochim. Biophys. Acta, 1761, 1213-1227.
38. Bienvenu, T. and Chelly, J. (2006) Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized. Nat. Rev. Genet., 7, 415-426.
39. Stancheva, I., Collins, A.L., Van den Veyver, I.B., Zoghbi, H. and Meehan, R.R. (2003) A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos. Mol. Cell, 12, 425-435.
40. Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., Fan, G. and Sun, Y.E. (2003) DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation. Science, 302, 890-893.
41. Karagianni, P. and Wong, J. (2007) HDAC3: taking the SMRTN-CoRrect road to repression. Oncogene, 26, 5439-5449.
42. Bhaskara, S., Chyla, B.J., Amann, J.M., Knutson, S.K., Cortez, D., Sun, Z.W. and Hiebert, S.W. (2008) Deletion of Histone Deacetylase 3 Reveals Critical Roles in S Phase Progression and DNA Damage Control. Mol. Cell, 30, 61-72.
43. Mergenthaler, P., Lindauer, U., Dienel, G.A. and Meisel, A. (2013) Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends Neurosci., 36, 587-597.
44. Banks, W.A., Owen, J.B. and Erickson, M.A. (2012) Insulin in the brain: there and back again. Pharmacol. Ther, 136, 82-93.
45. Calfa, G., Hablitz, J.J. and Pozzo-Miller, L. (2011) Network hyperexcitability in hippocampal slices from Mecp2 mutant mice revealed by voltage-sensitive dye imaging. J. Neurophysiol., 105, 1768-1784.
46. Zhang, W., Peterson, M., Beyer, B., Frankel, W.N. and Zhang, Z. (2014) Loss of MeCP2 from forebrain excitatory neurons leads to cortical hyperexcitation and seizures. J. Neurosci. Off. J. Soc. Neurosci., 34, 2754-2763.
47. Kron, M., Howell, C.J., Adams, I.T., Ransbottom, M., Christian, D., Ogier, M. and Katz, D.M. (2012) Brain Activity Mapping in Mecp2 Mutant Mice Reveals Functional Deficits in Forebrain Circuits, Including Key Nodes in the Default Mode Network, that are Reversed with Ketamine Treatment. J. Neurosci. Off. J. Soc. Neurosci, 32, 13860-13872.
48. Lundgaard, I., Li, B., Xie, L., Kang, H., Sanggaard, S., Haswell, J.D.R., Sun, W., Goldman, S., Blekot, S., Nielsen, M. et al. (2015) Direct neuronal glucose uptake heralds activity-dependent increases in cerebral metabolism. Nat. Commun., 6, 6807.
49. Conti, V., Gandaglia, A., Galli, F., Tirone, M., Bellini, E., Campana, L., Kilstrup-Nielsen, C., Rovere-Querini, P., Brunelli, S. and Landsberger, N. (2015) MeCP2 affects skeletal muscle growth and morphology through non cellautonomous mechanisms. PLoS One, 10.
50. Fyffe, S.L., Neul, J.L., Samaco, R.C., Chao, H.T., Ben-Shachar, S., Moretti, P., McGill, B.E., Goulding, E.H., Sullivan, E., Tecott, L.H. et al. (2008) Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress. Neuron, 59, 947-958.
51. Wang, X., Lacza, Z., Sun, Y.E. and Han, W. (2014) Leptin resistance and obesity in mice with deletion of methyl-CpG-binding protein 2 (MeCP2) in hypothalamic proopiomelanocortin (POMC) neurons. Diabetologia, 57, 236-245.
52. Sticozzi, C., Belmonte, G., Pecorelli, A., Cervellati, F., Leoncini, S., Signorini, C., Ciccoli, L., De Felice C., Hayek J. and Valacchi, G., (2013) Scavenger receptor B1 posttranslational modifications in Rett syndrome. FEBS Lett., 10.1016/j.febslet.2013.05.042.
53. Cooke, D.W., Naidu, S., Plotnick, L. and Berkovitz, G.D. (1995) Abnormalities of thyroid function and glucose control in subjects with Rett syndrome. Horm. Res., 43, 273-278.
54. Cronk, J.C., Derecki, N.C., Ji, E., Xu, Y., Lampano, A.E., Smirnov, I., Baker, W., Norris, G.T., Marin, I., Coddington, N. et al. (2015) Methyl-CpG binding protein 2 regulates microglia and macrophage gene expression in response to inflammatory stimuli. Immunity, 42, 679-691.
55. De Felice, C., Della Ragione, F., Signorini, C., Leoncini, S., Pecorelli, A., Ciccoli, L., Scalabrí, F., Marracino, F., Madonna, M., Belmonte, G. et al. (2014) Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome. Neurobiol. Dis., 68, 66-77.
56. Matsuishi, T., Urabe, F., Percy, A.K., Komori, H., Yamashita, Y., Schultz, R.S., Ohtani, Y., Kuriya, N. and Kato, H. (1994) Abnormal carbohydrate metabolism in cerebrospinal fluid in rett syndrome. J. Child Neurol., 9, 26-30.
57. Müller, M. and Can, K. (2014) Aberrant redox homoeostasis and mitochondrial dysfunction in Rett syndrome. Biochem. Soc. Trans., 42, 959-964.
58. Pfrieger, F.W. and Ungerer, N. (2011) Cholesterol metabolism in neurons and astrocytes. Prog. Lipid Res., 50, 357-371.
59. Kanungo, S., Soares, N., He, M. and Steiner, R.D. (2013) Sterol metabolism disorders and neurodevelopment-an update. Dev. Disabil. Res. Rev., 17, 197-210.
60. Schmidt, D., Wilson, M.D., Spyrou, C., Brown, G.D., Hadfield, J. and Odom, D.T. (2009) ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions. Methods San Diego Calif, 48, 240-248.
61. Guy, J., Gan, J., Selfridge, J., Cobb, S. and Bird, A. (2007) Reversal of neurological defects in a mouse model of Rett syndrome. Science, 315, 1143-1147.